NCT02218164 2022-10-07Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell CarcinomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed8 enrolled 11 charts
NCT01158274 2014-11-07RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed30 enrolled